1. Prolactine Case Presentation
The Road is NOT Always Straight
Usama Ragab Youssif, MD
Consultant Internal Medicine
Lecturer of Medicine
Zagazig University
Email: usamaragab@medicine.zu.edu.eg
Slideshare: https://www.slideshare.net/dr4spring/
Mobile: 00201000035863
2nd ENDO-ISMA 2020 – Hybrid Conference
2. Case 1
• A 51-year-old man presents with decreased libido and
erectile dysfunction and is found to have the following
laboratory values:
Testosterone = 197 ng/mL (300-900 ng/dL)
Prolactin = 39 ng/mL (4-23 ng/mL)
• A 14-mm pituitary adenoma is identified on MRI.
3. Case 1 (cont.)
• While taking cabergoline, 0.5 mg twice weekly, his PRL
and testosterone levels normalize and his libido and
erectile function improve.
• Two years later, he develops headaches and erectile
dysfunction again despite maintaining a normal PRL
level on cabergoline therapy.
4. Which of the following should be the next
management step?
A. Discontinue cabergoline
B. Switch cabergoline to bromocriptine
C. Increase the cabergoline dosage to 1.0 mg twice
weekly
D. Perform another pituitary-directed MRI
5. The correct Answer…
• Diagnosis is determined by basal PRL
levels, which generally correlate with
prolactinoma size
• Discrepancy between his PRL level of
only 39 ng/mL and the size of the
adenoma—14 mm.
• Although this discrepancy could be
due to inefficient production of
prolactin by a prolactinoma, it is more
likely due to stalk dysfunction.
• Microprolactinoma:
50 – 150 ng/mL
• Macroadenoma 1 – 2 cm:
200 – 1000 ng/mL
• If size > 2 cm:
1000 – 50000 ng/mL
BestPractResClinEndocrinolMetab.2019Apr;33(2):101290.
6. Stalk effect
• Suprasellar or sellar lesions extending
dorsally to involve the pituitary stalk can
lead to hyperPRL and galactorrhea
• Such lesion cause ↓ ↓ of dopamine
secretion from hypothalamus or its
transport to pituitary
• These lesion include large non-
functioning pituitary adenoma, germ cell
tumor, craniopharyngioma, Rathek’s cleft
cyst, meningioma etc…
• Generally PRL levels are rarely higher
than 100 mcg/L.
Americanfamilyphysician,85(11),1073-1080.
7. Cont.
• A dopamine agonist could indeed normalize PRL
levels and, if the hypogonadism were the result of
hyperprolactinemia, correct decreased libido and
erectile dysfunction but have no effect on the growth of
a mass lesion that is not a prolactinoma.
• He now has symptoms suggestive of hypogonadism
with a normal PRL, raising concerns about increased
mass effect = pituitary failure…
9. Which of the following should be the next
management step?
A. Discontinue cabergoline
It leads to normalization of PRL levels, it will be of benefit till more definitve treatment approaches used
B. Switch cabergoline to bromocriptine
The patient’s prolactin level has normalized with cabergoline at the current dosage, so there is no reason to
switch to bromocriptine
C. Increase the cabergoline dosage to 1.0 mg twice weekly
Increasing the cabergoline dosage would not help distinguish a prolactinoma from a nonsecreting tumor.
D. Perform another pituitary-directed MRI
Therefore, performing a pituitary directed MRI to assess for an increase in tumor size should be the next
management step, not stopping treatment (Answer A).
10. Stalk effect bottom line
• PRL levels generally correlate with tumor size
• Therefore, when a macroadenoma is present with PRL
level below 100 ng/mL, pituitary stalk compression
from a non-functioning tumor should be suspected for
the cause of the hyperprolactinemia, rather than
prolactinoma.
11. PRL levels vs symptoms vs tumor
1- If PRL is high but patient is asymptomatic = False Positive
= Macroprolactin
= Heterophil antibodies
2- If PRL is mildly elevated in presence of large tumor
= Stalk effect
= Hook effect = False Negative
3- If PRL is high, patient is symptomatic but non tumor is detected
= Other causes rather than adenoma e.g. another
endocrinopathy
Gibney et ai., JCEM 2005. Petakov et al., J endocrinol Invest 1998
13. History of PRL assay
• Following the discovery that pituitary
extracts induce milk production, a
relatively crude bioassay for PRL was
devised, based on the stimulation of
production of a milk-like substance by
the crop sacs of pigeons.
• However, because even very highly
purified preparations of human GH
have high lactogenic activity, it was
not possible to differentiate human
PRL from GH using this assay.
AmJPhysiol.1933;105:191–216
14. To Date PRL assay
• Now automated and employ
nonradioactive, enzymatic, or
chemiluminescent labels.
• These assays are based on the
sandwich principle in which the PRL
molecule reacts with both a capture
antibody, immobilized on a solid
phase, and a labeled detection
antibody, used to detect the PRL.
• After a wash step to remove unused
labeled antibody, the signal generated
is proportional to the concentration of
PRL in the sample.
NatureClinicalPracticeEndocrinology&Metabolism3,no.3(2007):279-289.
Capture Ab
Detection Ab
15. Case 2
• A 45-year-old man presents for evaluation off an elevated
PRL level.
• He is previously healthy and takes no medications or
supplements, but has recently been feeling depressed and
fatigued.
• As part of the evaluation, his PCP sent a set of blood tests.
• The comprehensive metabolic panel, thyroid function, and
CBC were normal.
16. Case 2 (cont.)
• In addition, the following results were obtained:
Total testosterone= 764 (240-950 ng /dL)
Free testosterone= 13.1 (4.26-16.4 ng /dL)
Prolactin= 39 (4-15.2 ng/mL)
• The patient denies any erectile dysfunction although he
does endorse some reduced libido since experiencing
low mood.
17. What is the next step in caring for this patient?
A. Request PRL level on serial dilutions of serum
B. Initiate bromocriptine therapy
C. Obtain a pituitary MRI
D. Order a macroprolactin level
E. Refer for neurosurgical evaluation
19. Macroprolactinemia
• Macroprolactin is an aggregate of
monomeric PRL molecule with
IgG which probably interferes with
reactivity between PRL and
antibodies (capture and detection)
involved in the sandwich reaction
of PRL immunoassays.
• PRL in this form has reduced
biologically activity but produces a
laboratory finding of
hyperprolactinemia.
20. Macroprolactinemia (cont.)
• False hyperprolactinemia =
misdiagnosis = mismanagement
• When hyperprolactinemia is detected,
is to sub-fractionate the serum, using
polyethylene glycol (PEG) 12.5%
• This procedure removes the higher
molecular weight forms of PRL by
precipitation, leaving the monomeric
forms in the supernatant.
EndocrPract.2015;21:1427-1435BestPractice&ResearchClinicalEndocrinology&Metabolism27(2013)725–742
21. What is the next step in caring for this patient?
A. Request PRL level on serial dilutions of serum
It is the evaluation of “hook effect”
B. Initiate bromocriptine therapy
Premature as true hyperprolactinemia is not confirmed
C. Obtain a pituitary MRI
Premature
D. Order a macroprolactin level
Most appropriate as the elevated levels of PRL is not correlated with symptoms or other lab
E. Refer for neurosurgical evaluation
Premature
22. Macroprolactin bottm line
• Don’t measure PRL unless symptomatic
• If symptoms equivocal & PRL levels are elevated,
consider assessing for macroprolactin (PEG
precipitation)
23. Heterophilic antibody
• Heterophilic Ab are human Ig capable
of recognizing animal Igs which
bridge the capture antibody and the
labeled antibody and, by mimicking
the role of the PRL, induce a false
signal
• Anti-animal antibodies (such as
human anti-mouse antibodies –
HAMA). More common in animal
handlers.
• May aggregate PRL (macro- one)
24. Innocent question?
Q: What is the problem in doing MRI for every one?
A: The big issue of pituitary incidentaloma…
25. Hook effect
• The “hook effect” is an artefact due
to saturation of the antibodies at
excessively high PRL
concentrations preventing
antibody-PRL-antibody sandwich
formation.
• Sandwich failure; PRL antigen
binds to separate antibodies
PrinciplesofNeurologicalSurgery(2012)
Sandwich failure…
26. Hook effect; the recommendation
• Therefore for large adenomas (> 3 cm) with a normal
PRL level, have the lab perform several dilutions
(1:100) of the serum sample and re-run the PRL,
especially in patients with clinical hyperprolcatinemia
(unless you know that your assay is not affected by
this).
29. As a rule of thumb
PRL levels correlates with the size of prolactinoma
But Remember
Stalk compression
Hook effect
We should DD between both conditions: Distinguish prolactinomas from clinically nonfunctioning adenomas.
Stalk dysfunction caused by a nonfunctioning adenoma or some other mass lesion such as a meningioma or Rathke cleft cyst.
Headaches and erectile dysfunction again despite maintaining a normal PRL level on cabergoline therapy?
Therefore, performing a pituitarydirected MRI to assess for an increase in tumor size should be the next management step, not stopping treatment (Answer A).
While levels greater than 250 ng/mL are suggestive of a macroprolactinoma, there are some medications that can raise PRL to this level.
= Schematic illustrates the principle of a two-site immunogenic assay for prolactin
The capture and labeled detection antibodies are each specific for a particular epitope on the PRL molecule.
PRL molecules polymerize and bind to immunoglobulins.
-----
Macroprolactin
Most is bound to IgG (24 – 86% oof macroprolactin, depending upon method)
Some may be heteromer
Less bioactive than monomeric
Another pitfall of the PRL assay is macroprolactin interference, which is more common with thecurrent generation of PRL immunoassays [60]. High molecular weight forms of PRL (150 kDa, bigebigPRL) pose a major problem due to their interference with PRL assays. These forms may result in afalse diagnosis of hyperprolactinemia that is not or is rarely accompanied by the usual signs ofhyperprolactinemia, i.e., amenorrhea and galactorrhea [59,61e64]. Macroprolactin is recognized byimmunoassays for PRL but has no biological activity in vivo. High concentrations of macroprolactinappear to be due to reduced clearance of IgG-PRL aggregates [65] and to their interference with thereactivity between PRL and the capture and detection antibodies involved in the sandwich reactionof PRL immunoassays [66]. All available immunoassays detect macroprolactin, but the variability isquite surprising, with 2.3- to 7.8-fold differences in detection levels [67]. False hyperprolactinemiarelated to macroprolactin is an important clinical issue because it may lead to misdiagnosis,mismanagement of patients, including unnecessary pituitary explorations, a waste of healthcareresources and unnecessary concerns for both patients and clinicians [68e75]. The prevalence ofmacroprolactinemia in hyperprolactinemic samples obtained in clinical practice has been evaluatedin different studies and reported to range from 15 to 46% [76]. When hyperprolactinemia is detectedin the first assay, clinicians are advised to obtain a control test from another laboratory that uses adifferent assay kit. If a major discrepancy is observed between the two results, particularly if one isnormal, then macroprolactinemia is the most likely explanation [63].
False hyperprolactinemia related to macroprolactin is an important clinical issue as it may lead to misdiagnosis and mismanagement of patients, including unnecessary pituitary exploration, a waste of healthcare resources, and unnecessary concerns for both patient and clinician.
The current best practice recommendation for clinical chemistry laboratories, when hyperprolactinemia is detected, is to sub-fractionate the serum, using polyethylene glycol (PEG) 12.5% (w/v).
This procedure removes the higher molecular weight forms of PRL by precipitation, leaving the monomeric forms in the supernatant.
Asymptomatic patients usually do not require treatment.
If monomeric PRL elevated, and/or patient symptomatic (amenorrhea, galactorrhea, ED…), exclude other causes (TSH, creatinine) and do MRI
If patient is symptomatic, do therapeutic trial with dopamine agonists.
Antibodies that could react against Ag of different species e.g. EBV detection, and rheumatic fever
When the sample PRL concentration exceeds the highest value in the calibration range, it can saturate the capture antibody bound to the solid phase. The number of sandwiches formed and, thus, the measured signal reaches a plateau.
----------
Extremely high levels of PRL may overwhelm the 2-site assay (the large number of PRL molecules prevent the formation of the necessary PRL-antibody-signal complexes for radioimmunoassay) and falsely low levels.
i.e. there is saturation of the antibodies with very high ligand levels
A high index of suspicion
Exclude pre-analytical problems
Repeat analysis on another instrument from a different manufacturer
Use of heterophile blocking tubes
PEG precipitation
Serial dilutions for positive interference
Serial dilutions for negative interference
Check using a different matrix e.g. urine for hCG
Solvent extraction
Selective removal of immunoglobulins
Column chromatography
Tandem-mass spec